Share this:
|
Funding Opportunities by Agency
| |
The Colorectal Cancer Alliance (the Alliance) is pleased to announce a Request for Proposals (RFP) for preclinical, translational and clinical research with the potential for high impact on treatment and survivorship of colorectal cancer. There are no application deadlines.
Applications will be accepted on a rolling basis.
| |
Discovery Boost Grants (DBG) high-risk, high-reward exploratory cancer research. Awards are for up to 2 years with $135,000 a year for direct costs, plus 10% allowable indirect costs. Due: 06/01/25
Mission Boost Grants (MBG) Stage I Mission Boost: $135,000/year direct cost for two years, plus 10% indirect costs. Stage II Mission Boost: Applicants may propose up to 18 months and $545,000 for direct costs, plus 10% indirect costs. Due: 06/01/25
Research Scholar Grants Awards are for up to 4 years with up to $215,000/year for direct costs, plus 10% allowable indirect costs. Due: 06/01/25
Postdoctoral Fellowship $66,000 Yr 1, $68,000 Yr 2, $70,0000 Yr 3, and additional $4,000/year Fellowship allowance. Due: 06/01/25
| |
Damon Runyon Fellowship Award Stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000, Yr 3, and $76,000 Yr 4 plus 2K/year expense allowance. The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Applications due by 08/15/25
Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award Stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000, Yr 3, and $76,000, Yr 4 plus 2K/year expense allowance. The Damon Runyon will retire up to $100,000 of any qualifying medical school debt still owed by the Fellow. Applications due: 08/15/25
| |
NOT-OD-23-032 Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards Up to 70K. Deadlines vary by awarding IC.
PAR-23-024 Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) Direct costs are limited to $350,000 per year. Due: 05/01/25
PAR-24-075 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Next due date:05/28/25
PAR-23-145 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) up to $250,000 direct costs/year. Due: 08/03/25
PA-24-194 NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed) Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects. Due: 06/12/25
| |
|
Vanderbilt-Ingram Cancer Center regularly solicits applications for pilot funding to support basic, translational, clinical or collaborative cancer research. Pilot funds allow investigators to collect preliminary data to support an application for independent research support through extramural, peer-reviewed funding. All pilot project awards are funded for one-year periods. For more information, contact us at viccresearchenterprise@vumc.org
| |
|
| NIH Standard Deadlines
P Series (New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25
R18, U18, R25 (New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25
T & D Series (New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25
C06/UC6 (New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25
June
R01 (New) Routing: 05/23/25, Sponsor: 06/05/25
U01 (New) Routing: 05/23/25, Sponsor: 06/05/25
K Series (New) Routing: 06/02/25, Sponsor: 06/12/25
R21 (New) Routing: 06/04/25, Sponsor: 06/16/25
July
R01 (Renewal, Resubmission, Revision) Routing: 06/25/25, Sponsor: 07/05/25
U01 (Renewal, Resubmission, Revision) Routing: 06/25/25, Sponsor: 07/05/25
K Series (New) Routing: 07/02/25, Sponsor: 07/12/25
R21 (New) Routing: 07/03/25, Sponsor: 07/16/25
August
F series (New, Renewal, Resubmission) Routing: 07/29/25, Sponsor: 08/08/25
R13, U13 (New, Renewal, Resubmission, Revision) Routing: 07/31/25, Sponsor: 08/12/25
| |
|
Additional Funding Opportunities:
| |
| Additional information is available via the following links:
| |
| Missing PMCIDs and other common errors on proposals
The PMI grants team encourages applicants to review these items often overlooked for compliance on NIH proposals. View...
| |
|
Planning a proposal submission in the next 2 - 3 months? In an effort to better serve you, the PMI grants team requests that PIs and Fellows notify us as far in advance as possible of submission plans. This ensures ample time to complete departmental requirements and also route to OSP for review by their deadline. Here is the link to the new SRS intake tool for new/resubmission requests: View...
| |
|
|
|
|
Vanderbilt University Medical Center 1161 21st Ave S | Nashville, TN 37232 US
|
|